Society Research Grants

Each Spring, in collaboration with MSK's Physician-in-Chief, The Society seeks proposals in clinical and translational research through The Society Research Grants Program. Working with Dr. José Baselga and his team, The Society's Finance Committee awards research grants that specifically focus on providing much needed funding opportunities for MSK's Junior Investigators. Since Dr. Baselga's arrival at MSK, his vision has been to focus The Society's grants on the increasingly important funding of early career researchers who are often at the height of their creativity an in need of independent funding for their work.

2018 Society Research Grant Recipients with Society President Jamee Gregory and Society Treasurer Kelley Johnston (center).
2018 Society Research Grant Recipients with Society President Jamee Gregory and Society Treasurer Kelley Johnston (center).

2018 Society Research Grants Program Award Recipients

Amy Robin Deipolyi, MD, PhD
The Interaction of PI3K Pathway Mutations and Immune Response in Mediating the Impact of Hepatic Arterial Radioembolization on Liver Metastasis Due to Breast Cancer

Daniel S. Higginson, MD
Early Detection of HPV-malignancies by Liquid Biopsy

Jonathan U. Peled, MD, PhD
Impact of the Intestinal Microbiome on Outcomes After Autologous Stem Cell Transplanation for Hematologic Malignancies

Bianca D. Santomasso, MD, PhD
A Prospective Neuroimaging and Neurocognitive Study of Patients Treated with CD19 CAR T Cell Therapy

Alison Schram, MD
Targeting SWI/SNF Complex Alterations for the Treatment of Endometrial Cancer and Endometriosis- Associated Ovarian Cancers

Jessica Scott, PhD
One Size May Not Fit All: Application of Precision Medicine to Guide Targeted Exercise Therapy

Alexander N. Shoushtari, MD
Identifying and Targeting ALK Aberrations in Melanomas Resistant to Standard Therapies

Neil Vasan, MD
Discovery and Validation of Tandem Mutations Driving Cancer

 

2017 Society Research Grants Program Award Recipients

Adrienne A. Boire, MD, PhD
Defining the CSF microenvironment in leptomeningeal metastasis

Eli L. Diamond, MD
Refining classification of histiocytoses and neoplasms of macrophage- dendritic cells on the basis of genetics

Samuel A. Funt, MD
The role of local and systemic anti-tumor immunity in functionally regulating response to cisplatin-based chemotherapy in bladder cancer

Neil M. Iyengar, MD
Obesity & Breast Cancer: Phase II study of a combined diet and structured exercise intervention to restore the dysregulated breast microenvironment in overweight/obese women

Elena Pentsova, MD
A "liquid biopsy" paradigm for tumor-derived DNA-based markers of the cerebrospinal fluid (CSF) for diagnosis and therapeutic monitoring of central nervous system (CNS) metastases in patients with stage IV cancer

George Plitas, MD
CD177 identifies a novel subset of regulatory T cells (Treg) infiltrating human breast cancer

Andreas Rimner, MD
Multicenter phase II toxicity study of IMPRINT (Intensity-modulated pleural radiation therapy) for locally advanced malignant pleural mesothelioma

Katie Thoren, PhD
MALDI-TOF mass spectrometry for the detection of monoclonal immunoglobins in serum

 

2016

Hikmat A. Al-Ahmadie, MD
Molecular Profiling of Micropapillary Urothelial Carcinoma

Andrea Cercek, MD
Patient Derived Organoid Models to Test Chemosensitivity of Appendiceal and Colorectal Adenocarcinomas Metastatic to the Peritoneum

Richard Kinh Gian Do, MD, PhD
Harnessing CT Radiomics to Predict Volumetric and Pathologic Response in Patients Treated for Colorectal Cancer Liver Metastases

Andrew S. Epstein. MD
Enhancing End-of-Life Care through Participation in Research Medical Donation

Mini Kamboj, MD
Development and Evaluation of a Robust Fingerprinting Tool for the Investigation of Hospital-Based Transmission of Clostridium Difficile

Heather J. Landau, MD
Identification of Genes That Regulate Light Chain (AL) Amyloid Pathogenesis and Clinical Outcomes

Irina Ostrovnaya, PhD
Using publicly Available Multi-Regional Sequencing Data to Identify the Accurate Summary Measure of Intra-Tumor Heterogeneity

J. Joshua Smith, MD, PhD
Defining the Role of SMAD4 in Rectal Cancer Using Primary Three Dimensional (3D) Tumor Cultures and a Novel Endoluminal Tumor Model

Martin H. Voss, MD
Mutation Profiling from Circulating Free Tumor DNA (cfDNA) in Patients with Advanced Kidney Cancer

 

2015

Yingbei Chen, MD, PhD
Investigating the Mechanistic Basis of Unclassified Aggressive Renal Cell Carcinoma with NF2-loss

Sandra D’Angelo, MD
Identifying Biomarkers Predictive of Response to Systematic Immunotherapy in Patients with Metastatic Merkel Cell Carcinoma

Liang Deng, MD, PhD
Inactivated Modified Vaccinia Virus Ankara (MVA) as Cancer Immunotherapy

Eli Diamond, MD
Phase Two Trial of Cobimetinib for the Treatment of Systemic Histiocytoses

Christian Grommes, MD
Correlating Genomic Alteration with Clinical Outcome Data and Signaling Pathways Status in Primary CNS Lymphoma

Gopakumar Iyer, MD
Genetic Profiling of Bladder Adenocarcinomas

Luc Morris, MD
Translating the Function of Novel Tumor Suppressor Gene Alterations in Head and Neck Cancer

Doris Ponce, MD
Study of Recombinant Human Interleukin-22 (F-652) for the Treatment of Grade II-IV Lower Gastrointestinal Acute Graft-versus-Host Disease in Hematopoietic Stem Cell Transplantation

Alexandra Snyder, MD
Introducing Recognition of Ovarian Cancers by the Immune System

 

2014

Mathew Hellman, MD
Exome sequencing to identify genetic predictors of response to anti-PD-1 therapy in patients with Advanced Lung Cancers

Sean McBride, MD, MPH
A Phase II randomized controlled screening trial of Nivolumab with image guided, stereotactic body radiotherapy (SBRT) versus Nivolumab alone in patients with metastatic head and neck Squamous Cell Carcinoma

Paul Paik, MD
A Phase 1 trial of Certolizumab in combination with chemotherapy for patients with Stage IV Lung Adenocarcinomas

Andrew Plodkowski, MD
Diffusion weighted imaging as a biomarker for early detection of chemotherapy induced cardiotoxicity

Martin Voss, MD
A Phase II trial of Dasatinib in combination with Bevacizumab for the treatment of metastatic High Grade Renal Cell Carcinoma

Robert Young, MD
In vivo MRI spectroscopy quantification of the 2-Hydoxyglutarate (2HG) Oncometabolite in mutant isocitrate Dehydogenase (IDH) Brain Glimoma and other human cancers

Johannes Zakrzewski, MD
Strategies to overcome transplantation barriers and treat hematologic malignancies enabled by small molecule-mediated inhibition of the transcription factor c-Rel

 

2013

Jamie E. Chaft, MD
Personalizing Pemetrexed Use in Lung Cancer through Tumor Genomic Analysis

Sarat Chandarlapaty, MD, PhD
Adaptive Resistance to Targeted Therapy of Hormone Driven Breast Cancer

David Chung, MD, PhD
MRNA-Electroplated Autologous Langerhans-type Dendritic Cell Vaccine as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Sean Devlin, PhD
Novel Statistical Methods for Incorporating Next Generation Sequencing Markers into an Existing Clinical Prognostic System

Darren Feldman, MD
A Clinical and Scientific Approach to Improving the Outcomes of Patients with Advanced Germ Cell Tumors

David Hyman, MD
Dasatinib in the Treatment of Clear Cell Ovarian Cancers with ARID1A Mutations

Diane Reidy, MD
Genetic Heterogeneity and Evolution of Treated Pancreatic Neuroendocrine Tumors

 

2012
 
Emily Cheng, MD
Therapeutic Induction of Cell Death in Human Malignancies
 
Michael Glickman, MD
Development of a Clinical Assay to Predict Susceptibility of Bladder Cancer to BCG Treatment
 
Ronald Hendrickson, MD
A Pilot Study to Apply a Modern Technique to Measure Activated Pathways in Chronic Lymphocytic Leukemia
 
Yelena Janjigian, MD
Identifying Gastric Cancer Patients Most Likely to Benefit from Hsp90 Therapy Through the Use of Tumor-Specific Biomarkers and PET Assay
 
Roisin O'Cearbhaill, MD
A phase II trial of Adjuvant WT1 analog peptide vaccine in patients with recurrent epithelial ovarian cancer who are in Second or Third Remission
 
Craig Sauter, MD
A phase I study of high-dose therapy and ASCT followed by CAR modified T cells directed against CD19 B cells for relapsed and refractory aggressive B cell NHL
 
Rona Yaeger, MD
Overcoming resistance in BRAF mutant colorectal cancer
 
 
2011
 
James Fagin, MD
Restoration of Radioiodine (RAI) Responsiveness in RAI-Refractory Thyroid Cancer
 
Moritz F. Kircher, MD
Combined Preoperative MRI/Intraoperative Raman Imaging of Brain Tumors Using A Novel Multimodal Nanoparticle
 
Christopher Park, MD
Novel Biomarkers for Minimal Residual Disease Detection and Therapeutic Targeting in AML
 
 
2010
 
Ngolela Esther Babady, MD
Development of a Multiplex Molecular Assay for the Diagnosis of Respiratory Viruses in Cancer Patients
 
Christopher DiMaio, MD
High Mobility Group Proteins as a Marker of Dysplasia in Pancreatic Cystic Neoplasms
 
Babak Mehrara, M.D.
Mechanisms of Fibrosis and Lymphatic Dysfunction in Lymphedema
 
Taha Merghoub, MD
Innovative Cominatin Immunotherapies and Targeted Therapies in Spontaneous Mouse Models of Melanoma
 
Hans-Guido Wendel, MD
MicroRNAs in Acute Lymphatic Leukemia
 
Pat Zanzonico, MD and Aurelian Radu, MD
PreClinical Molecular Imaging of the Follicle Stimulating Hormone Receptor (FSHR), A New Marker of Tumor Neovasculature
 
 
2009
 
Denise Correa, MD
Genetics of Treatment Related Cognitive and Brain Structural Changes in Brain Tumor Survivors
 
Jason Huse, MD
A Functional Analysis of microRNAs in Gliomagenesis
 
Andrew Lassman, MD
Phase I/II Clinical Trial of Perifosine and Tersirolimus in Recurrent Malignant Gliomas
 
Zsofia Stadler, MD
Testicular Germ Cell Tumors: Assessing Genomic Structural Variation in Cancer Susceptibility
 
Martin Weiser, MD
Genetic and Epigenetic Profiling to Predict Rectal Cancer Recurrence and Explain Disparity in Outcome Based on Race
 
 
2008
 
Juliet Barker, MD
Transplantation of Unrelated Donor Umbilical Cord Blood to Extend Transplant Access to Racial and Ethnic Minorities
 
Timothy Chan, MD
Discovery and Validation of Novel Colorectal Cancer Biomarkers Using Combined Genetic and Epigenetic Analysis
 
Jennifer Liu, MD
Improving Prediction of the Development of Cardiac Dysfunction in Breast Cancer Patients Treated with Adjuvant Chemotherapy with Trastuzumab
 
Pietra Cote Robson, RN
Impact of Palliative Catheter Placement on Quality of Life in Patients with Malignant Ascites
 
Vivian Strong, MD
Enhancing Minimally Invasive Surgery with Real-Time Intraoperative CAT SCAN Imaging
 
 
2007
 
Nai-Kong Cheung, MD
Multisensory Dance Movement Psychotherapy for Pain Control among Children undergoing Cancer Treatment
 
Ira Dunkel, MD
Neuropsychological testing for Children with Medulloblastoma
 
Mark Kayton, MD
Study of an Ethanol-Lock Strategy to Prevent Central Line Infections Among Patients with Neuroblastoma
 
Joanne Kelvin, RN
Coordination of Care for Patients with Head/Neck Cancer
 
Tara Leflein, MD
Canine Assisted Therapy
 
Robert Wittes, MD
Quality of Care Initiative
 
Jingbo Zhang, MD
Percutaneous MR-Guided Focused Ultrasound of Painful Osseous Metastases
 
 
2006
 
Ryan Branski, PhD
Neuromuscular Stim/Hypopharyngeal Cancer
 
Denise Correa, PhD
Adult Stem Cell - Cognitive Function Study
 
Mithat Gönen, PhD
Risk Predictions Liver Surgery Complications
 
Marcia Kalin, MD
Glycemic Control
 
Sara Olson, PhD
Genetic Susceptibility to Pancreatic Cancer
 
Trudy Small, MD
Vaccines in Peds Cancer Survivors
 
William Tew, MD
Ovarian Cancer Mgmt. Older Women
 
Martin Weiser, MD
Colorectal Outcome Prediction